Global Antifungal Drugs Market 2022-2028

August 2022 | 72 pages | ID: G2AF511D3815EN
Gen Consulting Company

Abstracts

According to Gen Consulting Company, the global antifungal drugs market is set to achieve an incremental growth of USD 4 billion, acelerating at a CAGR of almost 4.1% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antifungal drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antifungal drugs industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, infection type, drug type, indication, and region. The global market for antifungal drugs can be segmented by type: prescription, OTC. Among these, the OTC segment was accounted for the highest revenue generator in 2021. Antifungal drugs market is further segmented by infection type: superficial, topical. Based on drug type, the antifungal drugs market is segmented into: echinocandins, polyenes, azoles, antimetabolites, others. The azoles segment held the largest share of the global antifungal drugs market in 2021 and is anticipated to hold its share during the forecast period. On the basis of indication, the antifungal drugs market also can be divided into: dermatophytosis, aspergillosis, candidiasis, others. In 2021, the aspergillosis segment made up the largest share of revenue generated by the antifungal drugs market. Antifungal drugs market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

• prescription
• OTC

By infection type:

• superficial
• topical

By drug type:

• echinocandins
• polyenes
• azoles
• antimetabolites
• others

By indication:

• dermatophytosis
• aspergillosis
• candidiasis
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The market research report covers the analysis of key stake holders of the global antifungal drugs market. Some of the leading players profiled in the report include Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Gilead Sciences Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global antifungal drugs market.
• To classify and forecast the global antifungal drugs market based on type, infection type, drug type, indication, region.
• To identify drivers and challenges for the global antifungal drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antifungal drugs market.
• To identify and analyze the profile of leading players operating in the global antifungal drugs market.

Why Choose This Report

• Gain a reliable outlook of the global antifungal drugs market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Prescription
OTC

PART 6. MARKET BREAKDOWN BY INFECTION TYPE

Superficial
Topical

PART 7. MARKET BREAKDOWN BY DRUG TYPE

Echinocandins
Polyenes
Azoles
Antimetabolites
Others

PART 8. MARKET BREAKDOWN BY INDICATION

Dermatophytosis
Aspergillosis
Candidiasis
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 10. KEY COMPANIES

Astellas Pharma Inc.
Bausch Health Companies Inc.
Bayer AG
Dr. Reddy’s Laboratories Ltd.
Galderma S.A.
Gilead Sciences Inc.
Janssen Pharmaceuticals, Inc.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER